HCA Healthcare, Inc. 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2025. HCA Healthcare, Inc. is a leading U.S. health care services company operating 190 hospitals (179 general acute care, 7 behavioral, 4 rehabilitation), 121 freestanding ambulatory surgery centers, and 31 freestanding endoscopy centers across 19 U.S. states and England. The company employs approximately 320,000 people and focuses on providing comprehensive, cost-effective health care services.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Revenues | $75.600 billion | $70.603 billion | +7.1% |
| Net Income (Attributable to HCA) | $6.784 billion | $5.760 billion | +17.8% |
| Diluted EPS | $28.33 | $22.00 | +28.8% |
| Operating Cash Flow | $12.636 billion | $10.514 billion | +20.2% |
| Total Debt | $46.492 billion | $43.031 billion | +8.0% |
| Interest Expense | $2.248 billion | $2.061 billion | +9.1% |
| Capital Expenditures | $4.944 billion | $4.875 billion | +1.4% |
Margin Analysis: Salaries and benefits represented 43.5% of revenues in 2025 (down from 44.1% in 2024). The effective income tax rate was 23.2% in 2025 compared to 24.5% in 2024.
Material Changes vs. Prior Period
- Volume Growth: Consolidated admissions increased 2.7% and equivalent admissions (inpatient + outpatient) increased 2.9%. Revenue per equivalent admission rose 4.0%.
- Operational Efficiency: Days revenues in accounts receivable improved to 51 days in 2025 from 54 days in 2024.
- Uncompensated Care: The estimated cost of total uncompensated care increased to $4.605 billion in 2025 from $4.366 billion in 2024.
- Shareholder Returns: The company repurchased 26.739 million shares in 2025 (totaling ~$10.1 billion) compared to 17.798 million shares in 2024. Dividends increased to $2.88 per share in 2025 from $2.64 in 2024.
- Debt Structure: The company entered a new $8.0 billion senior unsecured credit facility and established a $4.0 billion commercial paper program, while terminating previous secured credit facilities.
Guidance, Outlook, and Risks
Management Commentary: Management attributes revenue growth to increased volume and revenue per admission. They anticipate continued pressure from the expiration of enhanced premium tax credits at the end of 2025 and changes from the 2025 Federal Budget Act (FBA), which may impact Medicaid financing and Exchange enrollment. The company is executing "financial resiliency initiatives" to offset these headwinds.
Capital Allocation: Planned capital expenditures for 2026 are expected to be between $5.0 billion and $5.5 billion. The company maintains a dividend program and an active share repurchase program ($750 million remaining under the Jan 2025 authorization as of year-end).
Key Risks:
- Regulatory & Policy: Significant uncertainty regarding the FBA's impact on Medicaid provider taxes, State Directed Payments (SDP), and eligibility requirements. Potential reductions in federal matching funds could force states to limit coverage.
- Reimbursement: Ongoing pressure from Medicare sequestration (2% cut through 2033) and site-neutral payment policies that may reduce reimbursement for outpatient services.
- Human Capital: Competition for nurses and physicians, potential unionization, and rising labor costs.
- Cybersecurity: Continued threat of ransomware and data breaches impacting operations and patient safety.
- Geographic Concentration: 51% of consolidated revenues are generated from facilities in Florida and Texas, creating sensitivity to local regulatory and economic conditions.
Investor Verification Checklist
- Medicaid Revenue Exposure: Verify the specific impact of the 2025 Federal Budget Act on State Directed Payments (SDP) and provider taxes in key states like Texas and Florida, as these programs contributed $6.2 billion to 2025 revenues.
- Uninsured Patient Trends: Monitor the expiration of enhanced premium tax credits and its effect on the uninsured rate and implicit price concessions, which totaled $7.674 billion in 2025.
- Debt Service Capacity: Assess the ability to service $46.5 billion in debt with an average effective interest rate of 5.0%, particularly given the shift to variable rate commercial paper ($2.2 billion outstanding).
- Professional Liability Reserves: Review the adequacy of the $2.044 billion reserve for professional liability risks, noting the $651 million provision for 2025 and the sensitivity of actuarial assumptions.
- Capital Expenditure Pipeline: Confirm the $7.1 billion in projects under construction and the ability to fund the projected $5.0–$5.5 billion 2026 capex plan without diluting liquidity.